Refocusing the AIM on HDL in the metabolic syndrome

Documenti analoghi

• Effect of rosiglitazone on HDL metabolism in subjects with metabolic syndrome and low HDL
  di: Millar, John S., et al.
  Pubblicazione: (2011)
• Metabolic Dysfunction in Heart Failure: Diagnostic, Prognostic, and Pathophysiologic Insights From Metabolomic Profiling
  di: Hunter, Wynn G., et al.
  Pubblicazione: (2016)
• A Novel Protein Glycan–Derived Inflammation Biomarker Independently Predicts Cardiovascular Disease and Modifies the Association of HDL Subclasses with Mortality
  di: McGarrah, Robert W., et al.
  Pubblicazione: (2016)
• HDL Subclass Analysis in Predicting Metabolic Syndrome in Koreans With High HDL Cholesterol Levels
  di: Yang, Hyun Suk, et al.
  Pubblicazione: (2020)
• Postmenopausal Women Have Higher HDL and Decreased Incidence of Low HDL than Premenopausal Women with Metabolic Syndrome
  di: Fernandez, Maria Luz, et al.
  Pubblicazione: (2016)